Melisa Williamson

Bio:

Melisa Williamson, Director GCP QA at Day One Biopharmaceuticals, focuses on building trust throughout her network of colleagues, vendors, and sites to improve efficiency and durability of processes.  Her work is largely influenced by the “father of the quality movement” W. Edwards Deming, the “grandfather of statistical quality control” Walter A. Shewart, and the founder of the Practical Process Improvement (PPI) method used to great result at Thermo Fisher Scientific, retired US Navy Captain and her mentor R.E. “Ed” Zunich.  Her early career provided experience in applying continuous improvement principles throughout many GXP environments. An experienced speaker, she was able to multiply forces early on by sharing these principles, ultimately gaining a reputation for being potently influential without authority.  After completing a B.S. in Biobehavioral Health at Pennsylvania State University she quickly rose to leadership roles at Pharm-Olam, an international CRO focused on rescue studies, building the QA department around her. More recently, she has managed and directed GCP Quality Assurance at Daiichi Sankyo, Abeona Therapeutics and now Day One Biopharmaceuticals.